Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Vertex Pharmaceuticals Incorporated
NCT07222137 · Diabetes Mellitus, Type 1
NCT06807190 · Diabetes Mellitus, Type 1
NCT07160816 · Diabetes Mellitus, Type 1
NCT07478211 · Diabetes Mellitus, Type 1, Energy Metabolism
NCT06748963 · Diabetes Mellitus, Type 1
City of Hope
Duarte, California
University of California San Francisco
San Francisco, California
UHealth Diabetes Research Institute
Miami, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions